Skip to content

Feasibility Clinical Study of NLA Tool-US

Evaluate the Feasibility of the NLA Tool, a Combined Assessment of Nutritional and Physical Functional Status, to Provide Personalized Advice for the Independence and Mobility of Elderly

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01995682
Acronym
NLA
Enrollment
154
Registered
2013-11-26
Start date
2013-12-31
Completion date
2014-07-31
Last updated
2014-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Independent living, walk with or without walking aids

Brief summary

The study is to evaluate the feasibility of the NLA tool, a combined assessment of nutritional and physical functional status, to provide personalized advice for the independence and mobility of elderly.

Detailed description

* Determining the proportion of elderly subjects who, according to the NLA result, would qualify for a personalized program to improve their nutritional and physical status; * Determining the segmentation (defined by cut-off criteria) of these elderly subjects stratified into 3 NLA subgroups according to strength and endurance performance (33% +/- 10% of target group)

Interventions

None listed

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
65 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

1. aged between 65 and 90 years, 2. able to walk with or without walking aid, 3. having obtained the subject's written informed consent 4. free of cognitive impairment (3MSE),

Exclusion criteria

1. self reported restriction to exercise(by a physician or other). 2. unable to carry out performance tests and questionnaires correctly, 3. self reported lower or upper extremity surgery or fracture in the last 3 months 4. self-reported symptomatic coronary artery disease, myocardial infarction in last 6 months 5. self reported history of neurological disease (e.g., Parkinson disease, stroke) with residual impairment 6. uncontrolled hypertension (\>150/90 mm Hg) 7. self reported congestive heart failure 8. unable to communicate in English. Non-English speaking individuals will be excluded due to safety concerns in being able to understand testing instructions.

Design outcomes

Primary

MeasureTime frameDescription
NLA feasibilityOne dayDetermining the proportion of elderly subjects who, according to the NLA result, would qualify for a personalized program to improve their nutritional and physical status.

Secondary

MeasureTime frameDescription
Evaluate the average time required for completing the NLAOne dayMeasure the time required to complete the NLA.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026